Supply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 1

Similar documents
Supply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 2

Supply of Fusidic Acid Cream 2% by Community Pharmacists for the treatment of impetigo in patients 2 years of age and over.

NHS Lothian Patient Group Direction Version: 001

Patient Group Direction For the supply of Fusidic Acid 2% Cream

PATIENT GROUP DIRECTION

Patient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders.

Job Title Name Signature Date

Expiry Date: January 2009 Template Version: Page 1 of 7

GG&C PGD ref no: 2011/841 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

Expiry Date: January 2009 Template Version: Page 1 of 7

NHS Fife. Patient Group Direction for Named Community Pharmacists to Supply

GG&C PGD ref no: 2017/1426 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

Patient Group Direction for ACICLOVIR (Version 02) Valid From 1 October September 2019

Patient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019

Name Job Title Signed Date. This Patient Group Direction is operational from: Oct 2017 Review date: Aug 19. Expires on 31 st October 2019

CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD)

PATIENT GROUP DIRECTION (PGD) FOR Metronidazole 400mg Tablets

Document Details. notification of entry onto webpage

Document Details. Patient Group Direction

Appendix 3 Cardiac Catheter Lab at Musgrove Park Hospital PATIENT GROUP DIRECTION (PGD)

PATIENT GROUP DIRECTION (PGD) FOR

PATIENT GROUP DIRECTION (PGD) FOR Amoxicillin 250mg/5ml Suspension

Patient Group Direction (PGD) template

GROUP PROTOCOL FOR THE MANAGEMENT OF SIMPLE MOUTH ULCERS. Version 4 December 2017

GG&C PGD ref no: 2018/1562 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

xrfslt \j,3 0+ {6^1 Otc(L!?i:lr+ NHS FIFE PRIMARY CARE THIS PATIENT GROUP DIRECTION HAS BEEN APPROVED BY:

THE TREATMENT OF BACTERIAL VAGINOSIS (BV) OR TRICHOMONAS VAGINALIS

NHS Greater Glasgow & Clyde Patient Group Direction (PGD) for Healthcare Professionals Typhoid vaccine (intra muscular administration)

PGDs are permitted for use only by registered health professionals (see enclosed link for full list

Best Practice Statement ~ March Patient Group Directions

Non-Medical Prescribing Passport. Reflective Log And Information

PATIENT GROUP DIRECTION. Hepatitis A + B Vaccine (Twinrix, Twinrix paediatric, Ambirix )

Dispensing Medications Practice Standard

Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES

Please call the Pharmacy Medicines Unit on or for a copy.

PATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OF DOXYCYCLINE 100MG CAPSULES / TABLETS FOR THE FIRST- LINE TREATMENT OF CHLAMYDIA TRACHOMATIS INFECTION

Patient Group Direction Policy

Best Practice Guidance for GP Practices, Community Pharmacists and Care Home Providers

Consultation Group: See relevant page in the PGD. Signature: 1. Review Date: November 2019

Patient Group Direction For The Administration Of Sodium Chloride (0.9%) Via Nebulisation By Physiotherapists Working Within NHS Grampian

Name Job Title Signed Date

PROTOCOL FOR THE ADMINISTRATION OF SENNA. Formulary and Prescribing Guidelines

FOR MEDICINE ADMINISTRATION IN COMMUNITY NURSING

PHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK

Fundamentals of Self-Limiting Conditions Prescribing for Manitoba Pharmacists. Ronald F. Guse Registrar College of Pharmacists of Manitoba (CPhM)

Non Medical Prescribing Policy Register No: Status: Public

PATIENT GROUP DIRECTION FOR AZITHROMYCIN

COMMUNITY PHARMACY MINOR AILMENTS SERVICE

All areas of the Trust All Trust staff All Patients Deputy Chief Nurse & Chief Pharmacist Final

ADMINISTRATION OF MEDICATION POLICY G&F ALTERNATIVE PROVISION SCHOOL

PROCESS FOR INITIATING A SYRINGE DRIVER FOR COMMUNITY NURSE PATIENTS OUT OF HOURS

GROUP PROTOCOL FOR THE MANAGEMENT OF SIMPLE INDIGESTION. Version 5 December 2017

NHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION)

Administering Medicine Policy

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines

SELF - ADMINISTRATION OF MEDICINES AND ADMINISTRATION OF MEDICINES SUPPORTED BY FAMILY/INFORMAL CARERS OF PATIENTS IN COMMUNITY NURSING

Administration of Medication Policy

Community Pharmacy. Chronic Medication Service Serial Prescriptions

Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP

Unlicensed Medicines Policy Document

First Aid and Medicine Policy. Date Adopted: May Next Review Date: May 2021

Managing medicines in care homes

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1

Competencies and Training Framework

Promoting Effective Immunisation Practice

Responsible pharmacist requirements: What activities can be undertaken?

Appendix 2 to NMP policy Prescribing Governance Framework Standards for Supplementary and Independent Non-Medical Prescribers at SCH

GROUP PROTOCOL FOR THE MANAGEMENT of HEARTBURN and ACID REFLUX. Version 4 January 2014

Medication Policy. Linked to National Quality Standards- Quality Area Two: Element Policy statement

2. Short term prescription medication and drugs (administered for less than two weeks):

Procedure to Allow Nursing Staff to Dispense Leave and Discharge Medication

Medicine Management Policy

PROCEDURE FOR IMMUNISATION

Improving compliance with oral methotrexate guidelines. Action for the NHS

INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY. Suffolk GP Federation Board

1. Guidance notes. Social care (Adults, England) Knowledge set for medication. What are knowledge sets? Why were knowledge sets commissioned?

Shared Care Agreements for Medicines

Unlicensed Medicines Policy

OPAT CELLULITIS PATHWAY

SFHPHARM29 - SQA Unit Code FA3A 04 Take a medication history

New To Therapy GuildCare Program

Appendix 2. Community Pharmacy Emergency Hormonal Contraception Service

Consultation Group: See relevant page in the PGD. Review Date: October 2015

PROCEDURE FOR THE ADMINISTRATION OF HOMELY REMEDIES IN COMMUNITY HOSPITALS

PATIENT GROUP DIRECTION (PGD) FOR THE

Medicines Management Strategy

National Emergency Medicine Programme. Protocol for the administration of Paracetamol (Acetaminophen) at Triage in the Emergency Department

Template (to be adapted by care home) Medication to be administered on a PRN (when required) basis in a care home environment

Best Practice Guidelines - BPG 9 Managing Medicines in Care Homes

abcdefghijklmnopqrstu

27: SCHOOL PUBLICATION SCHEME Last reviewed: December 2016 Next Review: December 2017 Approved by Governors Date: 6 th December 2016

Administration of Medication Policy and Procedures Sources of reference: see Appendix A POLICY

Medication Management Policy and Procedures

STANDARD OPERATING PROCEDURE ADMINISTRATION OF HEPARIN FLUSHES VIA CENTRAL INTRAVENOUS ACCESS DEVICES

The Prescribing, Monitoring and Administration of Depot / Long Acting IM Medication within Community Mental Health Services

STANDARD OPERATING PROCEDURE FOR SAFE AND SECURE MANAGEMENT OF CONTROLLED DRUGS WITHIN PRIMARY CARE DIVISION.

COMPASS Phase II Incident Analysis Report Prepared by ISMP CANADA February 2016

IBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

Competencies for NHS Health Check Enhanced Service using the General Level Framework & Service Specification

Medicines Management Policy

Transcription:

Supply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 Date protocol prepared: December 2015 Date protocol due for review: December 2017 This patient group direction must be signed by all health care professionals involved in its use. NHS Forth Valley should hold the original signed copy. The PGD must be easily accessible in the clinical setting. Organisation NHS Forth Valley Job Title Name Signature Date Director of Nursing Angela Wallace 16/2/16 Signed by Angela Wallace Medical Director Tracey Gillies Signed by Tracey Gillies 5/2/16 Director of Pharmacy Gail Caldwell Signed by Gail Caldwell 16/2/16 This document authorises the supply of Fusidic Acid 2% cream by appropriate practitioners to patients who meet the criteria for inclusion under the terms of the document. Practitioners seeking to supply Fusidic Acid 2% cream must ensure that they assess all clients to make sure they meet the criteria before supplying the product. The purpose of this Patient Group Direction is to help patients by ensuring that they have ready access to a quality assured service which provides a timely, consistent and appropriate supply of Fusidic Acid 2% cream for Impetigo.

Signatures of those developing the Patient Group Direction Job Title Name Signature Date Doctor Leslie Cruikshank Signed by Leslie Cruickshank 9/2/16 Pharmacist Kirstin McIntosh Signed by Kirstin McIntosh 4/2/16 Nurse Microbiologist (if appropriate) Paediatrician (if appropriate) Sara Jamdar Signed by Sara Jamdar 8/2/16 David Watson Signed by David Watson 13/2/16 Approval from Patient Group Directions Group Chair Signed on behalf of group Date Patient Group Directions Group Gail Caldwell Signed by Gail Caldwell 16/2/16 Signature of one GP on behalf of Practice OR Head of Service OR Employer to indicate that other professionals may undertake the work within the confines of the Patient Group Direction Name Signature Date Intranet version.doc - 2 -

The following Patient Group Direction for Supply of Fusidic Acid 2% cream for Impetigo by Community Pharmacists may be used from the following business/practice: Name: Address: YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT CLINICAL CONDITION Indication Treatment of minor staphylococcal skin infections. (Impetigo) Inclusion Criteria Exclusion Criteria Adults and children aged 2 years or older with minor skin infection limited to a few lesions in one area of body. The rash consists of vesicles that weep and then dry to form yellow-brown crusts. Must obtain parental/guardian consent for treating a child under the age of 16 years. Patient must be present at consultation. Multiple site skin infection. Children under the age of 2 years. Had impetigo within the last 3 months. Allergy to any component of the cream. Patient refuses treatment. Presenting with any underlying skin condition on the same area of the body as impetigo. Concerns with regarding patient compliance with topical medication. Caution/ Need for further advice Action if Patient declines or is excluded Refer patient to GP or OOHs for review DRUG DETAILS Name, form & strength of medicine Legal Status Route/ Method Dosage Frequency Duration of treatment Maximum or minimum treatment period Fusidic Acid 2% Cream POM Topical Apply to lesions Four times daily for 7 days. Apply Four times daily Maximum treatment 7 days. Use for a maximum of 7 days. Maximum of one supply in three months. Intranet version.doc - 3 -

Quantity to Supply/ administer Side Effects 1 x 15g tube Side effects with this product are rare however hypersensitivity reactions may occur For a full list of side effects refer to the marketing authorisation holder s Summary of Product Characteristics (SPC). A copy of the SPC must be available to the health professional administering medication under this Patient Group Direction. This can be accessed on www.medicines.org.uk All adverse reactions that are serious or result in harm should be reported to the MHRA through the Yellow Card Scheme. Advice to patient/carer Wash hands before and after applying cream. Where possible remove scabs by bathing in warm water before applying the cream. Impetigo is a very infectious condition. Important to prevent infection spreading by using own flannels and towels (hot wash after use). Do not scratch or pick spots. Suggest applying cream three times daily on school days and four times daily at other times. Inform school of condition. Do not share cream with anyone else. Inform of possible side effects and their management. The Drug Manufacturer Patient Information Leaflet should be given. Patients should be informed who to contact should they experience an adverse drug reaction Follow up If the skin infection spreads or there is no improvement after 5 days, seek medical advice from GP. STAFF CHARACTERISTICS Qualifications Pharmacist currently registered with the General Pharmaceutical Council. Specialist Has undertaken an antimicrobial / infection management CPD competencies or event in previous 12 months Qualifications Continuing Training & Education Up to date knowledge in therapeutic area Undertakes an antimicrobial/infection management CPD event annually Intranet version.doc - 4 -

REFERRAL ARRANGEMENTS & AUDIT TRAIL Referral arrangements Ensure patient is aware that if symptoms worsen or the skin infection spreads then they should seek medical advice either from their GP or through OOH centre. If symptoms have not improved after five days treatment, then patients should be advised to seek further medical advice. Records/audit trail A record of supply should be made on PMR which includes Name, strength, form and pack size of medicine supplies Dose and route of administration Date of supply and name of person making supply The medicine must be labelling in accordance with requirements detailed in the current version of Medicines, Ethics and Practice. The patient s GP must be notified that a supply has taken place. The patient s GP must be informed if the patient experiences an adverse drug reaction. A computer or manual record of all individuals receiving a supply under this PGD should also be kept for audit purposes. Any adverse events/incidents should be reported to the PGD group in addition to any existing pharmacy processes Reference sources and comments Records of supply should be kept for 8 years. Electronic Medicines Compendium (www.medicines.org.uk) Intranet version.doc - 5 -

PATIENT GROUP DIRECTION AUTHORISATION DOCUMENT Supply of Fusidic Acid 2% Cream by Community Pharmacists working in Forth Valley Pharmacies protocol number 472 Individual Authorisation This PGD does not remove inherent professional obligations or accountability It is the responsibility of each professional to practice only within the bounds of their own competence and in accordance with their own Code of Professional Conduct. It is also your responsibility to ensure that all consultations with patients occur within a private and confidential area of the pharmacy. I have read and fully understand the Patient Group Direction for the supply of Fusidic Acid 2% Cream and agree to provide this medicine only in accordance with this PGD in NHS Forth Valley Community Pharmacies. Name of Pharmacist GPhC Number Normal Pharmacy Location Signature Date The above person has been authorised to use this protocol Signature of Authorising Pharmacist on behalf of Employing Organisation Name Signature Date Note : A copy of this agreement must be signed by each pharmacist who wishes to be authorised to use the PGD for Supply of Fusidic Acid 2% by Community Pharmacists working in Forth Valley Pharmacies. Please return this form (page 6) to Pharmacy Services, Falkirk Community Hospital, Westburn Ave, Falkirk. FK1 5QE fax number 01324 673616 and retain a copy in each pharmacy premises they wish to provide the medicine from. A copy of the PGD must also be available in the pharmacy for reference. Each authorised pharmacy practitioner should be provided with an individual copy of the clinical content of the PGD and a photocopy of the document showing their authorisation. Intranet version.doc - 6 -